Donald I Abrams
Overview
Explore the profile of Donald I Abrams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1888
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Braun I, Bohlke K, Abrams D, Anderson H, Balneaves L, Bar-Sela G, et al.
J Clin Oncol
. 2024 Mar;
42(13):1575-1593.
PMID: 38478773
Purpose: To guide clinicians, adults with cancer, caregivers, researchers, and oncology institutions on the medical use of cannabis and cannabinoids, including synthetic cannabinoids and herbal cannabis derivatives; single, purified cannabinoids;...
2.
Scialo T, Pace C, Abrams D
Curr Oncol Rep
. 2024 Jan;
26(3):191-199.
PMID: 38289521
Purpose Of Review: Cancer risk reduction remains a significant concern for both individuals with a cancer diagnosis and those aiming to prevent it. Dairy products, a source of beneficial dietary...
3.
Dusek J, Gao Q, Kim R, Abrams D, Kligler B, Dyer N, et al.
Complement Ther Med
. 2022 Nov;
71:102904.
PMID: 36435299
Objective: To evaluate the real-world effectiveness of integrative medicine treatment on quality of life using the Patients Receiving Integrative Medicine Effectiveness Registry (PRIMIER). Design: A prospective, longitudinal, observational evaluation of...
4.
Braun I, Nayak M, Roberts J, Chai P, Tulsky J, Abrams D, et al.
JCO Oncol Pract
. 2022 Aug;
18(11):e1787-e1795.
PMID: 35969815
Purpose: A growing body of scientific research indicates that oncology teams tend to offer individuals with cancer little clinical advice regarding medicinal cannabis (MC) and that individuals with cancer instead...
5.
Abrams D
Integr Cancer Ther
. 2022 Feb;
21:15347354221081772.
PMID: 35225051
As medical cannabis becomes legal in more states, cancer patients are increasingly interested in the potential utility of the ancient botanical in their treatment regimen. Although eager to discuss cannabis...
6.
Braun I, Abrams D, Blansky S, Pergam S
J Natl Cancer Inst Monogr
. 2021 Dec;
2021(58):68-77.
PMID: 34850899
Session 2 of the National Cancer Institute's Cannabis, Cannabinoids, and Cancer Research Workshop opened with testimony from a lymphoma survivor who detailed medicinal cannabis-related improvements in nausea, low appetite, insomnia,...
7.
Cooper Z, Abrams D, Gust S, Salicrup A, Throckmorton D
J Natl Cancer Inst Monogr
. 2021 Dec;
2021(58):114-122.
PMID: 34850896
Significant changes have occurred in the policy landscape surrounding cannabis legalization, production, and use around the globe and across the United States. With widespread availability of novel cannabis and cannabis-based...
8.
Abrams D, Velasco G, Twelves C, Ganju R, Bar-Sela G
J Natl Cancer Inst Monogr
. 2021 Dec;
2021(58):107-113.
PMID: 34850894
The first evidence that cannabinoids may have in vitro and in vivo antineoplastic activity against tumor cell lines and animal tumor models was published in the Journal of the National...
9.
Hill K, Abrams D
J Cannabis Res
. 2021 Jul;
3(1):23.
PMID: 34215325
Background: With millions of people using cannabinoids to treat a host of medical conditions, clinicians want guidance on how to utilize cannabinoids as pharmacotherapy in their practices. The Delphi method...
10.